drugset / Trial / NCT00433277
Autoimmunity in Retinitis Pigmentosa
Unknown
Semmelweis University
Non-randomizedSingle-groupOpen-label
Summary
Using local immune suppression, the trial seeks evidence for the hypothesis that autoimmunity plays a role in the pathomechanism of retinitis pigmentosa.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 0.5 % | Other |